CKD Bio Corp. (063160.KS) KSC
19,490.00
-20(-0.10%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
19,490.00
-20(-0.10%)
Currency In KRW
| Market Cap | 111.7B |
| Enterprise Value | 111.7B |
| P/E Ratio | -37.04 |
| PEG Ratio | 0.09 |
| Price/Sales Ratio | 0.67 |
| Price/Book Ratio | 0.83 |
| Enterprise/Revenue | 1.54 |
| Enterprise/EBITDA | 24.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -0.02 |
| Operating Margin | 0.02 |
| Return On Assets | -0.01 |
| Return On Equity | -0.02 |
| Revenue | 160.07B |
| Revenue/Share | 29,159.53 |
| Gross Profit | 0 |
| EBITDA | 3.61B |
| Net Income | -2.89B |
| Diluted EPS | -526.16 |
| Total Cash | 1.04B |
| Total Cash/Share | 189.58 |
| Total Debt | 139.82B |
| Total Debt/Equity | 1.09 |
| Current Ratio | 0.92 |
| Book Value Per Share | 23,439.78 |
| 52-Week Change | -2.5 |
| 52-Week High | 27,650 |
| 52-Week Low | 18,390 |
| Moving Average 50 Days | 20,646.4 |
| Moving Average 200 Days | 22,016.1 |
| Average Volume | 59,025 |
| Shares Outstanding | 5.49M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.19 |
| Last Split Factor | 21:20 |
| Last Split Date | December 27, 2019 |